Citation: X. Leloet et al., COMBINATIONS OF 2ND-LINE DRUGS FOR RHEUMATOID-ARTHRITIS - IS REMISSION INDUCTION A REASONABLE GOAL, Revue du rhumatisme, 65(3), 1998, pp. 161-164
Authors:
BENIZEAU I
CAMBONMICHOT C
DARAGON A
VOISIN L
MEJJAD O
THOMINE JM
LELOET X
Citation: I. Benizeau et al., TENDINITIS OF THE TIBIALIS ANTERIOR WITH HISTOLOGIC DOCUMENTATION IN A PATIENT UNDER FLUOROQUINOLONE THERAPY, Revue du rhumatisme, 64(6), 1997, pp. 432-433
Authors:
JOUENBEADES F
VITTECOQ O
DARAGON A
MENARD JF
KRZANOWSKA K
LELOET X
TRON F
Citation: F. Jouenbeades et al., CYTOKINE PRODUCTION IN WHOLE-BLOOD CELL-CULTURE OF PATIENTS WITH EARLY RHEUMATOID-ARTHRITIS - LOW PRODUCTION OF IFN-GAMMA AND IL2, Arthritis and rheumatism, 40(9), 1997, pp. 1005-1005
Authors:
VITTECOQ O
JOUENBEADES F
KRZANOWSKA K
DELPECH A
MENARD JF
DARAGON A
TRON F
LELOET X
Citation: O. Vittecoq et al., RHEUMATOID-FACTOR DETECTED BY ELISA, ANTI-FILAGGRIN AND ANTI-SA ANTIBODIES ARE USEFUL MARKERS FOR EARLY DIAGNOSIS OF COMMUNITY CASES OF RHEUMATOID-ARTHRITIS, Arthritis and rheumatism, 40(9), 1997, pp. 1335-1335
Authors:
VITTECOQ O
SCHAEVERBEKE T
FAVRE S
DARAGON A
BIGA N
CAMBONMICHOT C
BEBEAR C
LELOET X
Citation: O. Vittecoq et al., MOLECULAR DIAGNOSIS OF UREAPLASMA-UREALYTICUM IN AN IMMUNOCOMPETENT PATIENT WITH DESTRUCTIVE REACTIVE POLYARTHRITIS, Arthritis and rheumatism, 40(11), 1997, pp. 2084-2089
Authors:
DUJARDIN F
ENNEDAM J
DARAGON A
BIGA N
THOMINE JM
Citation: F. Dujardin et al., EXPERIMENTAL-STUDY OF THE STABILIZATION C APABILITY OF DIFFERENT EXTERNAL FIXATORS IN THE UPPER METAPHYSEAL TIBIAL FRACTURES, Revue de chirurgie orthopedique et reparatrice de l'appareil moteur, 82(6), 1996, pp. 500-507
Authors:
MEJJAD O
DARAGON A
LOUVEL JP
DASILVA LF
THOMINE E
LAURET P
LELOET X
Citation: O. Mejjad et al., OSTEOARTICULAR MANIFESTATIONS OF PUSTULOSIS PALMARIS-ET-PLANTARIS ANDOF PSORIASIS - 2 DISTINCT ENTITIES, Annals of the Rheumatic Diseases, 55(3), 1996, pp. 177-180
Authors:
FACON T
MENARD JF
MICHAUX JL
EULLERZIEGLER L
BERNARD JF
GROSBOIS B
DARAGON A
AZAIS I
COUROUBLE Y
KAPLAN G
LAPORTE JP
DEGRAMONT A
DUCLOS B
LEONARD A
MINEUR P
DELANNOY A
JOUET JP
BAUTERS F
MONCONDUIT M
Citation: T. Facon et al., PROGNOSTIC FACTORS IN LOW TUMOR MASS ASYMPTOMATIC MULTIPLE-MYELOMA - A REPORT ON 91 PATIENTS, American journal of hematology, 48(2), 1995, pp. 71-75
Authors:
DARAGON A
MEJJAD O
CZERNICHOW P
LOUVEL JP
VITTECOQ O
DURR A
LELOET X
Citation: A. Daragon et al., VERTEBRAL HYPEROSTOSIS AND DIABETES-MELLITUS - A CASE-CONTROL STUDY, Annals of the Rheumatic Diseases, 54(5), 1995, pp. 375-378
Citation: X. Leloet et A. Daragon, NUTRITIONAL THERAPY FOR ACTIVE ARTHRITIS IN PREGNANT OR BREAST-FEEDING WOMEN - PRELIMINARY-OBSERVATIONS - REPLY, Journal of rheumatology, 21(5), 1994, pp. 968-968
Authors:
DESHAYES P
LELOET X
MEJJAD O
DARAGON A
POTTIER S
Citation: P. Deshayes et al., DESTRUCTIVE JOINT LESIONS IN PATIENTS WIT H CROHNS-DISEASE - A REPORTOF 3 CASES, Revue du rhumatisme, 60(9), 1993, pp. 625-627
Authors:
MATHIOT C
TEILLAUD JL
MOSSERI V
EULLERZIEGLER L
DARAGON A
GROSBOIS B
MICHAUX JL
FACON T
BERNARD JF
DUCLOS B
LAPORTE JP
MONCONDUIT M
FRIDMAN WH
Citation: C. Mathiot et al., STAGE CORRELATION OF SOLUBLE CD16 LEVEL IN MYELOMA PATIENTS, Experimental hematology, 21(8), 1993, pp. 1126-1126
Authors:
GANCEL A
LEVESQUE H
MABILAIS P
DARAGON A
COURTOIS H
Citation: A. Gancel et al., IMPROVEMENT OF INAUGURAL CUTANEOUS XANTHOMATOSIS WITH THERAPY DURING MULTIPLE-MYELOMA - A CASE-REPORT WITH A 3 YEARS FOLLOW-UP, La Revue de medecine interne, 14(5), 1993, pp. 320-322
Authors:
MATHIOT C
GROSBOIS B
TEILLAUD JL
TARTOUR E
MOSSERI V
EULLERZIEGLER L
DARAGON A
MICHAUX JL
FACON T
BERNARD JF
DUCLOS B
LAPORTE JP
MONCONDUIT M
FRIDMAN WH
Citation: C. Mathiot et al., CORRELATION BETWEEN SERUM LEVELS OF SOLUB LE CD16 AND STAGES OF MYELOMA - STUDY ON 214 SERUM SAMPLES, La Revue de medecine interne, 14(10), 1993, pp. 960-960